Exocrine pancreatic insufficiency (EPI) in dogs
EPI is a condition in which the exocrine pancreas does not produce enough digestive enzymes, mainly lipase, proteases, and amylase. The result is maldigestion: food is eaten but nutrients are not adequately digested or absorbed.
It is usually a lifelong but very manageable disease when correctly diagnosed and treated.
Common causes
-
Pancreatic acinar atrophy (PAA)
- Immune-mediated destruction and loss of enzyme-producing pancreatic acinar cells.
- A frequent cause in young adult dogs, especially German Shepherd Dogs, Rough Collies, and some other predisposed breeds.
-
Chronic pancreatitis
- Recurrent or chronic pancreatic inflammation can progressively destroy pancreatic tissue.
- More common in middle-aged or older dogs and can occur in any breed.
-
Less common causes
- Pancreatic tumor or pancreatic-duct obstruction
- Congenital pancreatic hypoplasia
- Severe pancreatic injury
Clinical signs
The classic pattern is:
- Weight loss despite a normal or increased appetite (polyphagia)
- Large-volume, pale, loose, poorly formed stool
- Foul-smelling stool
- Increased stool frequency
- Flatulence and borborygmi, or loud gut sounds
- Poor hair coat, muscle loss, lethargy
- Coprophagia, eating feces, in some dogs
Stools may appear greasy, but not every dog has obvious steatorrhea. Vomiting, poor appetite, or marked lethargy are not typical primary signs of EPI and should prompt assessment for concurrent disease.
Diagnosis
1. Canine trypsin-like immunoreactivity (cTLI)
Serum cTLI is the preferred and most specific diagnostic test for canine EPI. It measures pancreatic trypsinogen and related molecules in the blood.
- Collect blood after withholding food for 12-18 hours.
- A cTLI concentration of ≤ 5.5 µg/L is diagnostic for EPI.
- 5.6-7.5 µg/L is equivocal or subnormal. If signs fit EPI, clinicians may begin an enzyme trial and repeat a fasted cTLI in 1-2 months.
- 7.6-10.8 µg/L is subnormal but makes EPI less likely.
- 10.9-50 µg/L is within the reference interval.
These current interpretive ranges are published by the
Texas A&M GI Laboratory. Serum TLI is also identified as the diagnostic test of choice in the
Merck Veterinary Manual.
2. Cobalamin (vitamin B12) and folate
Measure serum cobalamin and folate at diagnosis.
- Cobalamin deficiency is common in EPI because pancreatic secretions are needed for normal B12 absorption and because intestinal dysbiosis can consume B12.
- Low B12 is associated with a poorer response unless it is corrected.
- Folate can help assess concurrent small-intestinal disease or dysbiosis, but it is not diagnostic by itself.
3. Supporting baseline tests
A veterinarian commonly also performs:
- CBC
- Serum biochemistry profile
- Urinalysis
- Fecal parasite testing, including Giardia assessment when appropriate
- Abdominal ultrasound if pancreatitis, pancreatic mass, biliary disease, intestinal disease, or other pathology is suspected
Ultrasound may show a small or abnormal pancreas, but a normal ultrasound does not rule out EPI.
4. Tests that are less useful
- Fecal elastase is less reliable than cTLI in dogs because low values can occur in healthy dogs and dogs with small-intestinal disease.
- Routine amylase and lipase activities do not diagnose EPI.
- Pancreatic lipase testing, such as cPLI, is primarily used when evaluating pancreatitis, not EPI.
Important differential diagnoses
Dogs with chronic diarrhea and weight loss do not automatically have EPI. Important alternatives or concurrent disorders include:
- Chronic inflammatory enteropathy
- Food-responsive enteropathy
- Intestinal lymphoma or other neoplasia
- Giardiasis and other parasites
- Protein-losing enteropathy
- Intestinal dysbiosis
- Diabetes mellitus
- Liver disease
- Addison's disease
- Chronic pancreatitis with or without EPI
A dog with low-normal or borderline cTLI and chronic intestinal disease needs careful interpretation, because intestinal disease can sometimes lower cTLI without true clinical EPI.
Treatment
1. Pancreatic enzyme replacement therapy (PERT)
This is the main treatment. The missing enzymes are mixed with every meal to digest food in the intestinal tract.
Preferred form
Pancreatic enzyme powder is generally preferred. It is usually more effective than tablets, capsules, and enteric-coated products.
A commonly used initial dosage is:
- 1 teaspoon of pancreatic enzyme powder per 10 kg body weight with each meal
This is an initial guide, not a substitute for the exact product-specific instructions from the treating veterinarian. Products differ in enzyme concentration, so dose adjustments should be based on clinical response.
How to give it
- Mix the powder thoroughly into food at every meal.
- Feed 2-3 meals per day initially if feasible.
- Enzyme treatment is generally lifelong.
- Once the dog is stable, the dose can sometimes be gradually reduced to the lowest dose that keeps body weight and stool normal.
Alternative: fresh pancreas
Fresh raw chopped pancreas has historically been used if commercial powder is unavailable, but it is less convenient, has variable enzyme content, and carries food-handling risks. Commercial veterinary enzyme products are usually preferable.
Adverse effects
The principal adverse effect is oral irritation or bleeding of the mouth, particularly with high doses of dry powder.
If this occurs, contact the veterinarian. Options may include:
- Reducing the enzyme dose if clinically appropriate
- Ensuring the powder is thoroughly mixed into moist food
- Reviewing whether the dog is receiving more enzyme than needed
- Assessing for another oral problem
Do not stop treatment abruptly in a dog dependent on enzymes without veterinary advice.
2. Correct cobalamin deficiency
If B12 is low, it should be supplemented. A current professional reference lists either:
- Parenteral cobalamin: 25 micrograms/kg subcutaneously once weekly in dogs, or
- Oral cobalamin: 25 micrograms/kg by mouth once daily in dogs.
The regimen should be individualized and B12 should be rechecked to confirm adequate correction. The
Merck Veterinary Manual provides these veterinary dosing examples. Both oral and injectable B12 have evidence of effectiveness in affected dogs, including a 2022 veterinary clinical study indexed as
PMID 36054643.
3. Diet
There is no single mandatory “EPI diet.”
Many dogs do well on a consistent, complete, good-quality commercial diet once enzyme replacement is effective. If response is incomplete, veterinarians often consider:
- Highly digestible diet
- Low-residue diet
- Lower-fiber diet
- Moderate-fat diet or a diet with highly digestible fat
- Avoidance of sudden diet changes
Very low-fat diets are not automatically required for every EPI dog. They may be useful when concurrent pancreatitis or fat intolerance is present. Dietary response should guide the plan.
Avoid unnecessary diet hopping. Change diets gradually and only with a defined reason.
4. Address poor response and concurrent intestinal disease
If the dog does not improve despite appropriate enzyme use and B12 supplementation, reassess rather than simply escalating enzyme doses indefinitely.
Common reasons for inadequate response:
- Incorrect diagnosis or another disease is present
- Enzyme is not given with every meal
- Enzyme dose or formulation is inadequate
- Untreated cobalamin deficiency
- Poor diet digestibility or excessive dietary fiber
- Concurrent chronic enteropathy
- Dysbiosis
- Parasites, especially Giardia
- Poor medication adherence
Dogs with EPI frequently have intestinal microbiome abnormalities. Antimicrobials such as tylosin may help selected dogs, but antibiotics should not be used automatically or indefinitely. They are best reserved for dogs with persistent signs after basic therapy and appropriate investigation. A recent canine EPI review is available as
PMID 37944252.
Monitoring response
Clinical improvement is usually noticeable within days to a few weeks after effective treatment begins.
Track:
- Body weight, ideally weekly at first
- Body condition and muscle condition
- Appetite
- Stool volume, frequency, consistency, color, and odor
- Vomiting or abdominal discomfort
- Flatulence
- Energy level
- Serum cobalamin after supplementation
A useful outcome is not simply “less diarrhea.” The aim is stable or increasing body weight, normal or near-normal stool, good appetite, and normal activity.
Routine repeat cTLI is usually not necessary once EPI has been clearly confirmed, unless the diagnosis was initially equivocal. Rechecking B12 is more useful, since deficiency can develop later.
Prognosis
The prognosis is usually good to excellent if:
- EPI is recognized early
- Enzyme replacement is given reliably with every meal
- B12 deficiency is corrected
- Concurrent intestinal disease is managed
Most dogs can have a normal quality of life, although the treatment and feeding routine are generally lifelong. Prognosis is less favorable when there is severe malnutrition, persistent hypocobalaminemia, major chronic intestinal disease, cancer, or poor treatment adherence.
When to seek urgent veterinary care
Seek prompt veterinary assessment if an affected dog has:
- Refusal to eat
- Repeated vomiting
- Severe lethargy or collapse
- Abdominal pain
- Black, tarry stool or visible blood
- Rapid weight loss
- Severe watery diarrhea or signs of dehydration
- Mouth ulcers or oral bleeding after starting enzyme powder
These signs can indicate dehydration, pancreatitis, gastrointestinal bleeding, adverse effects, or another concurrent disorder rather than uncomplicated EPI.